Inhibition of the growth of papillary thyroid carcinoma cells by CI-1040.

Abstract

BACKGROUND Papillary thyroid carcinoma (PTC), the most common type of thyroid malignancy, usually possesses mutations, either RET/PTC rearrangement or BRAF mutation. Both mutations can activate the mitogen-activated protein kinase kinase/extracellular signal-related kinase signaling transduction pathway, which results in activation of transcription factors… (More)
DOI: 10.1001/archoto.2009.17

Topics

4 Figures and Tables

Cite this paper

@article{Henderson2009InhibitionOT, title={Inhibition of the growth of papillary thyroid carcinoma cells by CI-1040.}, author={Ying C. Henderson and Soon-Hyun Ahn and Gary L Clayman}, journal={Archives of otolaryngology--head & neck surgery}, year={2009}, volume={135 4}, pages={347-54} }